s.flexneriza-s.sonnei bivalent conjugate vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jul 18, 2017 (NCT03561181)
Timeline
Indications
Mechanism of action
- ShigellaImmunity, active
Shigella immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06838195 | Phase 3 | Apr 15, 2025 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| NCT05156528 | Phase 3 | Dec 11, 2021 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| NCT04865497 | Phase 2 | Jan 19, 2019 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| NCT03561181 | Phase 1 | Jul 18, 2017 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 4 | 4 | 3 | 2017 |
1 organizations
Page 1 / 1